ALB and Alzheimer disease: Furthermore, in vitro and in vivo experiments utilizing Caenorhabditis elegans as a model demonstrated that HSA-BFP@CDs effectively suppressed Aβ aggregation and mitigated oxidative stress in vivo, underscoring the potential and prospects of protein-carbon dot conjugates in the multi-targeted treatment of AD.